title: Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study.
abstract: A diagnosis of ovarian cysts is likely an indicator of hormonal milieu and thus may be related to breast cancer risk. Recent studies have reported an inverse relationship between prior ovarian cyst diagnosis and breast cancer risk. We evaluated this relationship in the Women's Contraceptive and Reproductive Experiences (CARE) Study, a population-based case-control study conducted in Atlanta, Detroit, Philadelphia, Los Angeles, and Seattle. Cases had first primary invasive breast cancer diagnosed between 1994 and 1998 at ages 35-64 years. African American women were over-sampled. Controls were identified through random digit dialling and were frequency matched to cases on centre, race, and five-year age group. A total of 4575 cases and 4682 controls were interviewed. We used unconditional logistic regression adjusted for age and study centre within racial groups to estimate the odds ratio (OR) and 95% confidence interval (CI) for the relationship between prior ovarian cysts and breast cancer. Ovarian cyst diagnosis was associated with a significantly reduced risk among Caucasians (OR=0.85, 95% CI 0.76-0.96) and among African Americans (OR=0.68, 95% CI 0.57-0.81). The association in Caucasians was not significant within subgroups defined by menopausal status, hormone use, or gynecological surgery while the OR estimates in African Americans were consistently lower and frequently significant. These data are consistent with the previously reported inverse association between ovarian cysts and breast cancer, but the evidence for a relationship was stronger in African Americans than Caucasians. Additional studies are required to determine the specific cyst type(s) responsible for the observed relationship.
authors.affiliation: Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 60 Murray Street, Box 18, Toronto, ON, Canada, M5T 3L9. knight@mshri.on.ca
authors.forename: Julia A
authors.initials: JA
authors.lastname: Knight
authors.forename: Maia
authors.initials: M
authors.lastname: Lesosky
authors.forename: Kristina M
authors.initials: KM
authors.lastname: Blackmore
authors.forename: Lynda F
authors.initials: LF
authors.lastname: Voigt
authors.forename: Victoria L
authors.initials: VL
authors.lastname: Holt
authors.forename: Leslie
authors.initials: L
authors.lastname: Bernstein
authors.forename: Polly A
authors.initials: PA
authors.lastname: Marchbanks
authors.forename: Ronald T
authors.initials: RT
authors.lastname: Burkman
authors.forename: Janet R
authors.initials: JR
authors.lastname: Daling
authors.forename: Alice S
authors.initials: AS
authors.lastname: Whittemore
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000235:genetics*; D016022:Case-Control Studies; D003270:Contraceptive Agents / Q000494:pharmacology*; D005260:Female; D006728:Hormones / Q000378:metabolism; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D016017:Odds Ratio; D010048:Ovarian Cysts / Q000150:complications / Q000175:diagnosis* / Q000235:genetics*; D012306:Risk; D012307:Risk Factors
chemical_list: D003270:Contraceptive Agents; D006728:Hormones